Evidence map›Paper›PMID 32666178›Full record

ReviewClinical rheumatology2021

Multiple endocrine neoplasia type 1 revealed by a hip pathologic fracture.

Maroua Slouma, Maissa Abbes, Rim Dhahri, Noureddine Litaiem, Nour Gueddiche, Nada Mansouri, Issam Msekni, Imen Gharsallah, Leila Metoui, Bassem Louzir

Abstract readCase ReportsReview
PubMed Publisher
In one paragraph

Review in Clinical rheumatology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Neuroendocrine neoplasia and bone (Review).Experimental and therapeutic medicine · 2021
    Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Maroua SloumaDepartment of Internal Medicine, Military Hospital, 1007, Tunis, Tunisia. maroua.slouma@gmail.com.ORCID http://orcid.org/0000-0002-6889-9687
Maissa AbbesDepartment of Internal Medicine, Military Hospital, 1007, Tunis, Tunisia.
Rim DhahriDepartment of Internal Medicine, Military Hospital, 1007, Tunis, Tunisia.
Noureddine LitaiemFaculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia.
Nour GueddicheDepartment of Internal Medicine, Military Hospital, 1007, Tunis, Tunisia.
Nada MansouriFaculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia.
Issam MsekniFaculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia.
Imen GharsallahDepartment of Internal Medicine, Military Hospital, 1007, Tunis, Tunisia.
Leila MetouiDepartment of Internal Medicine, Military Hospital, 1007, Tunis, Tunisia.
Bassem LouzirDepartment of Internal Medicine, Military Hospital, 1007, Tunis, Tunisia.
Tunis University · TNMilitary Hospital of Tunis · TN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multiple endocrine neoplasia type 1 is a rare autosomal inherited syndrome that affects a variety of endocrine tissues such as the parathyroid, endocrine pancreas, and anterior pituitary. Osseous complications are often misdiagnosed. We presented a case of a 46-year-old woman with pathological fractures of the lower limb. She had a history of type 1 diabetes and galactorrhea. Laboratory examinations showed hypercalcemia and an increased level of parathyroid hormone related to hyperparathyroidism. Serum chromogranin A level was increased at 9369 ng/mL (N < 102). A somatostatin receptor scintigraphy (octreoscan) revealed pathological uptake in the gastric wall, later cave adenopathy, and liver. The diagnosis of multiple endocrine neoplasia type 1 was made based on radiological and histological findings. The patient underwent a subtotal parathyroidectomy associated with somatostatin analog treatment leading to significant improvement. A literature review was conducted by searching PubMed using these following terms: multiple endocrine neoplasia type 1, hyperparathyroidism, fracture, menin, osteoporosis. We emphasized bone involvement related to multiple endocrine neoplasia type 1 syndrome. This diagnosis should be considered when pathological fractures occur in young patients with a history of endocrine disorder. We highlighted the importance of imaging features in making the diagnosis of multiple endocrine neoplasia type 1. Early management of this disease is necessary. Treatment including parathyroidectomy and somatostatin analogs leads to bone preservation and functional improvement.

Indexed as

Fractures, SpontaneousHyperparathyroidismMultiple Endocrine Neoplasia Type 1FemaleHumansMiddle AgedNeoplasm Recurrence, LocalParathyroidectomyFractureHyperparathyroidismMeninMultiple endocrine neoplasia type 1Osteoporosis

Identifiers

PMID32666178
OpenAlexW3043622674

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.